According to filings with the U.S. Securities and Exchange Commission, Genvax Technologies is raising up to $5,249,991.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joel Harris played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Genvax Technologies
Genvax is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation RNA + nanoparticle vaccines for animal health. This isnt the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015. Our Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can. Our Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.

To learn more about Genvax Technologies, visit http://genvax.com/
Company Linkedin Page: https://www.linkedin.com/company/genvax/

Contact:
Joel Harris, Chief Executive Officer
515-686-4676
https://www.linkedin.com/in/joel-harris-58bb6119/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.